The emerging roles of AhR in physiology and immunity

Biochemical Pharmacology

Volumn 86, Issue 5, 2013, Pages 561-570

  Hao, Nan ^a   Whitelaw, Murray L ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

AhR; Immunity; Th17; Treg

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; LIPOPOLYSACCHARIDE;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; DENDRITIC CELL; GAMMA DELTA T LYMPHOCYTE; GENE INACTIVATION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; IMMUNOREGULATION; INFLUENZA VIRUS; MACROPHAGE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TH1 CELL; TH1 TH2 BALANCE; TH2 CELL; WOUND HEALING;

EID: 84884901570     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.07.004     Document Type: Note

References (117)

1. Kewley RJ, Whitelaw ML, Chapman-Smith A. The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. The International Journal of Biochemistry & Cell Biology 2004;36:189-204. (Pubitemid 37487755)
2. Coumailleau P, Poellinger L, Gustafsson JA, Whitelaw ML. Definition of a minimal domain of the dioxin receptor that is associated with Hsp90 and maintains wild type ligand binding affinity and specificity. The Journal of Biological Chemistry 1995;270:25291-300.
3. Waller CL, McKinney JD. Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: model validation and Ah receptor characterization. Chemical Research in Toxicology 1995;8:847-58.
4. Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by struc-turally diverse exogenous and endogenous chemicals. Annual Review of Pharmacology and Toxicology 2003;43:309-34. (Pubitemid 37372644)
5. Whelan F, Hao N, Furness SG, Whitelaw ML, Chapman-Smith A. Amino acid substitutions in the aryl hydrocarbon receptor ligand binding domain reveal YH439 as an atypical AhR activator. Molecular Pharmacology 2010;77:1037-46.
6. McMillan BJ, Bradfield CA. The aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proceedings of the National Academy of Sciences of the United States of America 2007;104:1412-7. (Pubitemid 46184018)
7. Cho YC, Zheng W, Jefcoate CR. Disruption of cell-cell contact maximally but transiently activates AhR-mediated transcription in 10T1/2 fibroblasts. Tox-icology and Applied Pharmacology 2004;199:220-38. (Pubitemid 39208723)
8. Hao N, Lee KL, Furness SG, Bosdotter C, Poellinger L, Whitelaw ML. Xenobio-tics and loss of cell adhesion drive distinct transcriptional outcomes by aryl hydrocarbon receptor signaling. Molecular Pharmacology 2012;82: 1082-93.
9. Enan E, Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlor-odibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochemical Pharmacology 1996;52:1599-612. (Pubitemid 26375466)
10. Park S, Dong B, Matsumura F. Rapid activation of c-Src kinase by dioxin is mediated by the Cdc37-HSP90 complex as part of Ah receptor signaling in MCF10A cells. Biochemistry 2007;46:899-908. (Pubitemid 46133606)
11. Lo R, Matthews J. High-resolution genome-wide mapping of AHR and ARNT binding sites by ChIP-Seq. Toxicological Sciences 2012;130:349-61.
12. Adachi J, Mori Y, Matsui S, Matsuda T. Comparison of gene expression patterns between 2,3,7,8-tetrachlorodibenzo-p-dioxin and a natural arylhydrocarbon receptor ligand, indirubin. Toxicological Sciences 2004;80:161-9. (Pubitemid 38967407)
13. Hayes KR, Zastrow GM, Nukaya M, Pande K, Glover E, Maufort JP, et al. Hepatic transcriptional networks induced by exposure to 2,3,7,8- tetrachlorodibenzo-p-dioxin. Chemical Research in Toxicology 2007;20:1573-81. (Pubitemid 350275602)
14. Huang G, Elferink CJ. A novel nonconsensus xenobiotic response element capable of mediating aryl hydrocarbon receptor-dependent gene expression. Molecular Pharmacology 2012;81:338-47.
15. Bock KW, Kohle C. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochemical Pharmacology 2006;72: 393-404. (Pubitemid 44061741)
16. Okey AB, Vella LM, Harper PA. Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice nonresponsive to induction of cytochrome P 1-450 by 3-methylcholanthrene. Molecular Pharmacology 1989;35:823-30. (Pubitemid 19180673)
17. Mimura J, Yamashita K, Nakamura K, Morita M, Takagi TN, Nakao K, et al. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes to Cells 1997;2:645-54. (Pubitemid 127688610)
18. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodi- benzo-p-dioxin-induced toxicity. Toxicology and Applied Pharmacology 1996;140:173-9. (Pubitemid 26329475)
19. Schmidt JV, Su GH, Reddy JK, Simon MC, Bradfield CA. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proceedings of the National Academy of Sciences of the United States of America 1996;93:6731-6. (Pubitemid 26230378)
20. Bunger MK, Moran SM, Glover E, Thomae TL, Lahvis GP, Lin BC, et al. Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. The Journal of Biological Chem-istry 2003;278:17767-74. (Pubitemid 36799380)
21. Andersson P, McGuire J, Rubio C, Gradin K, Whitelaw ML, Pettersson S, et al. A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proceedings of the National Academy of Sciences of the United States of America 2002;99:9990-5. (Pubitemid 34831160)
22. Moennikes O, Loeppen S, Buchmann A, Andersson P, Ittrich C, Poellinger L, et al. A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Research 2004;64:4707-10. (Pubitemid 38924510)
23. Konig J, Nies AT, Cui Y, Leier I, Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochimica et Biophysica Acta 1999;1461:377-94.
24. Davarinos NA, Pollenz RS. Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export. The Journal of Biological Chemistry 1999;274:28708-15.
25. Pollenz RS. The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and nonhepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Molecular Pharmacology 1996;49:391-8.
26. Roberts BJ, Whitelaw ML. Degradation of the basic helix-loop-helix/Per- ARNT-Sim homology domain dioxin receptor via the ubiquitin/ proteasome pathway. The Journal of Biological Chemistry 1999;274: 36351-56.
27. Berg P, Pongratz I. Differential usage of nuclear export sequences regulates intracellular localization of the dioxin (aryl hydrocarbon) receptor. The Journal of Biological Chemistry 2001;276:43231-38.
28. Ikuta T, Kobayashi Y, Kawajiri K. Cell density regulates intracellular localiza-tion of aryl hydrocarbon receptor. The Journal of Biological Chemistry 2004;279:19209-16. (Pubitemid 38623352)
29. Mimura J, Ema M, Sogawa K, Fujii-Kuriyama Y. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes and Devel-opment 1999;13:20-5. (Pubitemid 29045112)
30. Evans BR, Karchner SI, Allan LL, Pollenz RS, Tanguay RL, Jenny MJ, et al. Repression of aryl hydrocarbon receptor (AHR) signaling by AHR repressor: role of DNA binding and competition for AHR nuclear translocator. Molecular Pharmacology 2008;73:387-98. (Pubitemid 351159209)
31. Oshima M, Mimura J, Yamamoto M, Fujii-Kuriyama Y. Molecular mechanism of transcriptional repression of AhR repressor involving ANKRA2, HDAC4, and HDAC5. Biochemical and Biophysical Research Communications 2007;364: 276-82. (Pubitemid 47633413)
32. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995;268:722-6.
33. Lahvis GP, Lindell SL, Thomas RS, McCuskey RS, Murphy C, Glover E, et al. Portosystemic shunting and persistent fetal vascular structures in aryl hy-drocarbon receptor-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 2000;97:10442-47.
34. Abbott BD, Schmid JE, Pitt JA, Buckalew AR, Wood CR, Held GA, et al. Adverse reproductive outcomes in the transgenic Ah receptor-deficient mouse. Toxi-cology and Applied Pharmacology 1999;155:62-70. (Pubitemid 29102762)
35. Baba T, Mimura J, Nakamura N, Harada N, Yamamoto M, Morohashi K, et al. Intrinsic function of the aryl hydrocarbon (dioxin) receptor as a key factor in female reproduction. Molecular and Cellular Biology 2005;25:10040-51. (Pubitemid 41573694)
36. Thomae TL, Glover E, Bradfield CA. A maternal Ahr null genotype sensitizes embryos to chemical teratogenesis. The Journal of Biological Chemistry 2004;279:30189-94. (Pubitemid 38937943)
37. Hushka LJ, Williams JS, Greenlee WF. Characterization of 2,3,7,8-tetrachlor-odibenzofuran-dependent suppression and AH receptor pathway gene ex-pression in the developing mouse mammary gland. Toxicology and Applied Pharmacology 1998;152:200-10. (Pubitemid 28498689)
38. Tijet N, Boutros PC, Moffat ID, Okey AB, Tuomisto J, Pohjanvirta R. Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-inde-pendent gene batteries. Molecular Pharmacology 2006;69:140-53. (Pubitemid 43048901)
39. McMillan BJ, Bradfield CA. The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems. Molecular Pharmacology 2007;72:487-98. (Pubitemid 47347283)
40. Ohtake F, Fujii-Kuriyama Y, Kato S. AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions. Biochemical Pharmacology 2009;77: 474-84.
41. Tian Y. Ah receptor and NF-kappaB interplay on the stage of epigenome. Biochemical Pharmacology 2009;77:670-80.
42. Denison MS, Soshilov AA, He G, Degroot DE, Zhao B. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicological Sciences 2011;124: 1-22.
43. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 2003;144:3382-98. (Pubitemid 36904414)
44. Ohtake F, Baba A, Takada I, Okada M, Iwasaki K, Miki H, et al. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 2007;446:562-6. (Pubitemid 46514731)
45. Meyer ME, Gronemeyer H, Turcotte B, Bocquel MT, Tasset D, Chambon P. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 1989;57:433-42. (Pubitemid 19126276)
46. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 2003;423:545-50. (Pubitemid 36648579)
47. Kim DW, Gazourian L, Quadri SA, Romieu-Mourez R, Sherr DH, Sonenshein GE. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene 2000;19:5498-506. (Pubitemid 32000917)
48. Fritsche E, Schafer C, Calles C, Bernsmann T, Bernshausen T, Wurm M, et al. Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proceedings of the National Academy of Sciences of the United States of America 2007;104:8851-6. (Pubitemid 47175400)
49. Quintana FJ. The aryl hydrocarbon receptor: a molecular pathway for the environmental control of the immune response. Immunology 2013;138: 183-9.
50. Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008;453:65-71. (Pubitemid 351630328)
51. Zhang L, Ma J, Takeuchi M, Usui Y, Hattori T, Okunuki Y, et al. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regu-latory T cells via activation of aryl hydrocarbon receptor. Investigative Ophthalmology & Visual Science 2010;51:2109-17.
52. Benson JM, Shepherd DM. Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease. Toxicological Sciences 2011;120:68-78.
53. Kerkvliet NI, Steppan LB, Vorachek W, Oda S, Farrer D, Wong CP, et al. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes. Immu-notherapy 2009;1:539-47.
54. Fujimaki H, Nohara K, Kobayashi T, Suzuki K, Eguchi-Kasai K, Tsukumo S, et al. Effect of a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin on immune function in male NC/Nga mice. Toxicological Sciences 2002;66: 117-24. (Pubitemid 34202033)
55. Schulz VJ, Smit JJ, Willemsen KJ, Fiechter D, Hassing I, Bleumink R, et al. Activation of the aryl hydrocarbon receptor suppresses sensitization in a mouse peanut allergy model. Toxicological Sciences 2011;123:491-500.
56. Luebke RW, Copeland CB, Daniels M, Lambert AL, Gilmour MI. Suppression of allergic immune responses to house dust mite (HDM) in rats exposed to 2,3,7,8-TCDD. Toxicological Sciences 2001;62:71-9. (Pubitemid 32611363)
57. Head JL, Lawrence BP. The aryl hydrocarbon receptor is a modulator of anti-viral immunity. Biochemical Pharmacology 2009;77:642-53.
58. Esser C. The immune phenotype of AhR null mouse mutants: not a simple mirror of xenobiotic receptor over-activation. Biochemical Pharmacology 2009;77:597-607.
59. Nohara K, Pan X, Tsukumo S, Hida A, Ito T, Nagai H, et al. Constitutively active aryl hydrocarbon receptor expressed specifically in T-lineage cells causes thymus involution and suppresses the immunization-induced increase in splenocytes. Journal of Immunology 2005;174:2770-7 (Pubitemid 40279693)
60. Nagai H, Kubo M, Abe R, Yamamoto M, Nohara K. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway. International Immu-nopharmacology 2006;6:279-86. (Pubitemid 43052825)
61. Laiosa MD, Wyman A, Murante FG, Fiore NC, Staples JE, Gasiewicz TA, et al. Cell proliferation arrest within intrathymic lymphocyte progenitor cells causes thymic atrophy mediated by the aryl hydrocarbon receptor. Journal of Immunology 2003;171:4582-91. (Pubitemid 37310574)
62. Fine JS, Silverstone AE, Gasiewicz TA. Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Journal of Immunology 1990;144: 1169-76. (Pubitemid 20072879)
63. Temchura VV, Frericks M, Nacken W, Esser C. Role of the aryl hydrocarbon receptor in thymocyte emigration in vivo. European Journal of Immunology 2005;35:2738-47. (Pubitemid 41404057)
64. McMillan BJ, McMillan SN, Glover E, Bradfield CA. 2,3,7,8-Tetrachlorodi- benzo-p-dioxin induces premature activation of the KLF2 regulon during thymocyte development. The Journal of Biological Chemistry 2007;282: 12590-97. (Pubitemid 47100644)
65. Casado FL, Singh KP, Gasiewicz TA. The aryl hydrocarbon receptor: regulation of hematopoiesis and involvement in the progression of blood diseases. Blood Cells Molecules and Diseases 2010;44:199-206.
66. Singh KP, Casado FL, Opanashuk LA, Gasiewicz TA. The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations. Biochemical Pharmacology 2009;77: 577-87.
67. Singh KP, Garrett RW, Casado FL, Gasiewicz TA. Aryl hydrocarbon receptor-null allele mice have hematopoietic stem/progenitor cells with abnormal characteristics and functions. Stem Cells and Development 2011;20:769-84.
68. Bertazzi PA, Pesatori AC, Bernucci I, Landi MT, Consonni D. Dioxin exposure and human leukemias and lymphomas. Lessons from the Seveso accident and studies on industrial workers. Leukemia 1999;13(Suppl. 1):S72-4.
69. Hooiveld M, Heederik DJ, Kogevinas M, Boffetta P, Needham LL, Patterson Jr DG, et al. Second follow-up of a Dutch cohort occupationally exposed to phenoxy herbicides, chlorophenols, and contaminants. American Journal of Epidemiology 1998;147:891-901. (Pubitemid 28243462)
70. Moser M, Leo O. Key concepts in immunology. Vaccine 2010;28(Suppl. 3): C2-13.
71. Kadow S, Jux B, Zahner SP, Wingerath B, Chmill S, Clausen BE, et al. Aryl hydrocarbon receptor is critical for homeostasis of invariant gammadelta T cells in the murine epidermis. Journal of Immunology 2011;187:3104-10.
72. Jux B, Kadow S, Esser C. Langerhans cell maturation and contact hypersensi-tivity are impaired in aryl hydrocarbon receptor-null mice. Journal of Im-munology 2009;182:6709-17.
73. Kiss EA, Vonarbourg C, Kopfmann S, Hobeika E, Finke D, Esser C, et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lym-phoid follicles. Science 2011;334:1561-5.
74. Li Y, Innocentin S, Withers DR, Roberts NA, Gallagher AR, Grigorieva EF, et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocar-bon receptor activation. Cell 2011;147:629-40.
75. Kerkvliet NI. AHR-mediated immunomodulation: the role of altered gene transcription. Biochemical Pharmacology 2009;77:746-60.
76. Stockinger B, Hirota K, Duarte J, Veldhoen M. External influences on the immune system via activation of the aryl hydrocarbon receptor. Seminars in Immunology 2011;23:99-105
77. Stevens EA, Mezrich JD, Bradfield CA. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology 2009;127:299-311.
78. Teske S, Bohn AA, Regal JF, Neumiller JJ, Lawrence BP. Activation of the aryl hydrocarbon receptor increases pulmonary neutrophilia and diminishes host resistance to influenza A virus. American Journal of Physiology - Lung Cellular and Molecular Physiology 2005;289:L111-24. (Pubitemid 40863561)
79. Choi JY, Oughton JA, Kerkvliet NI. Functional alterations in CD11b(+)Gr-1(+) cells in mice injected with allogeneic tumor cells and treated with 2,3,7,8- tetrachlorodibenzo-p-dioxin. International Immunopharmacology 2003;3: 553-70. (Pubitemid 36419516)
80. Ackermann MF, Gasiewicz TA, Lamm KR, Germolec DR, Luster MI. Selective inhibition of polymorphonuclear neutrophil activity by 2,3,7,8-tetrachloro- dibenzo-p-dioxin. Toxicology and Applied Pharmacology 1989;101:470-80. (Pubitemid 20027776)
81. Nguyen NT, Kimura A, Nakahama T, Chinen I, Masuda K, Nohara K, et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proceedings of the National Academy of Sciences of the United States of America 2010;107:19961-66.
82. Vorderstrasse BA, Kerkvliet NI. 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects the number and function of murine splenic dendritic cells and their expres-sion of accessory molecules. Toxicology and Applied Pharmacology 2001;171:117-25. (Pubitemid 32221686)
83. Lee JA, Hwang JA, Sung HN, Jeon CH, Gill BC, Youn HJ, et al. 2,3,7,8-Tetra-chlorodibenzo-p-dioxin modulates functional differentiation of mouse bone marrow-derived dendritic cells Downregulation of RelB by 2,3,7,8-tetra-chlorodibenzo-p-dioxin. Toxicology Letters 2007;173:31-40.
84. Ruby CE, Funatake CJ, Kerkvliet NI. 2,3,7,8 Tetrachlorodibenzo-p-dioxin (TCDD) directly enhances the maturation and apoptosis of dendritic cells in vitro. Journal of Immunotoxicology 2005;1:159-66.
85. Yeste A, Nadeau M, Burns EJ, Weiner HL, Quintana FJ. Nanoparticle- mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 2012;109:11270-75.
86. Hauben E, Gregori S, Draghici E, Migliavacca B, Olivieri S, Woisetschlager M, et al. Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 2008;112:1214-22.
87. Quintana FJ, Murugaiyan G, Farez MF, Mitsdoerffer M, Tukpah AM, Burns EJ, et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Pro-ceedings of the National Academy of Sciences of the United States of America 2010;107:20768-73.
88. Kimura A, Naka T, Nakahama T, Chinen I, Masuda K, Nohara K, et al. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. Journal of Experimental Medicine 2009;206: 2027-35.
89. Masuda K, Kimura A, Hanieh H, Nguyen NT, Nakahama T, Chinen I, et al. Aryl hydrocarbon receptor negatively regulates LPS-induced IL-6 production through suppression of histamine production in macrophages. International Immunology 2011;23:637-45.
90. Sulentic CE, Kaminski NE. The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p- dioxin. Toxicological Sciences 2011;120(Suppl. 1):S171-91.
91. North CM, Crawford RB, Lu H, Kaminski NE. 2,3,7,8-tetrachlorodibenzo-p- dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation. Toxicological Sciences 2010;116:99-112.
92. Negishi T, Kato Y, Ooneda O, Mimura J, Takada T, Mochizuki H, et al. Effects of aryl hydrocarbon receptor signaling on the modulation of TH1/TH2 balance. Journal of Immunology 2005;175:7348-56. (Pubitemid 41713431)
93. Inouye K, Pan X, Imai N, Ito T, Takei T, Tohyama C, et al. T cell-derived IL-5 production is a sensitive target of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Chemosphere 2005;60:907-13. (Pubitemid 40898139)
94. Lawrence BP, Denison MS, Novak H, Vorderstrasse BA, Harrer N, Neruda W, et al. Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound. Blood 2008;112:1158-65.
95. Ettmayer P, Mayer P, Kalthoff F, Neruda W, Harrer N, Hartmann G, et al. A novel low molecular weight inhibitor of dendritic cells and B cells blocks allergic inflammation. American Journal of Respiratory and Critical Care Medicine 2006;173:599-606. (Pubitemid 43363800)
96. Morales JL, Krzeminski J, Amin S, Perdew GH. Characterization of the anti-allergic drugs 3-[2-(2-phenylethyl) benzoimidazole-4-yl]-3-hydroxypropa- noic acid and ethyl 3-hydroxy-3-[2-(2-phenylethyl)benzoimidazol-4- yl]propanoate as full aryl hydrocarbon receptor agonists. Chemical Research in Toxicology 2008;21:472-82.
97. Kerkvliet NI, Baecher-Steppan L, Shepherd DM, Oughton JA, Vorderstrasse BA, DeKrey GK. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlor- odibenzo-p-dioxin. Journal of Immunology 1996;157:2310-9. (Pubitemid 126450440)
98. Vorderstrasse BA, Steppan LB, Silverstone AE, Kerkvliet NI. Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model anti-gens and are resistant to TCDD-induced immune suppression. Toxicology and Applied Pharmacology 2001;171:157-64. (Pubitemid 32217666)
99. Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. Journal of Immunology 2010;185:3190-8.
100. Frericks M, Meissner M, Esser C. Microarray analysis of the AHR system: tissue-specific flexibility in signal and target genes. Toxicology and Applied Pharmacology 2007;220:320-32. (Pubitemid 46627841)
101. Funatake CJ, Marshall NB, Steppan LB, Mourich DV, Kerkvliet NI. Cutting edge: activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodi- benzo-p-dioxin generates a population of CD4+ CD25+ cells with character-istics of regulatory T cells. Journal of Immunology 2005;175:4184-8. (Pubitemid 41361950)
102. Singh NP, Singh UP, Singh B, Price RL, Nagarkatti M, Nagarkatti PS. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS ONE 2011;6:e23522.
103. Marshall NB, Vorachek WR, Steppan LB, Mourich DV, Kerkvliet NI. Functional characterization and gene expression analysis of CD4+ CD25+ regulatory T cells generated in mice treated with 2,3,7,8-tetrachlorodibenzo-p- dioxin. Journal of Immunology 2008;181:2382-91.
104. Kerkvliet NI, Shepherd DM, Baecher-Steppan L. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodi- benzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD. Toxicology and Applied Pharmacology 2002;185:146-52. (Pubitemid 36062805)
105. Vogel CF, Goth SR, Dong B, Pessah IN, Matsumura F. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochemical and Biophysical Research Communications 2008;375:331-5.
106. Heyes MP, Brew BJ, Saito K, Quearry BJ, Price RW, Lee K, et al. Inter-relation-ships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. Journal of Neuroimmunology 1992;40:71-80.
107. Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992;115(Pt 5): 1249-73.
108. Silver RM, McKinley K, Smith EA, Quearry B, Harati Y, Sternberg EM, et al. Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome. Arthritis and Rheumatism 1992;35: 1097-105.
109. Platten M, Ho PP, Youssef S, Fontoura P, Garren H, Hur EM, et al. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 2005;310:850-5. (Pubitemid 41567343)
110. Marshall NB, Kerkvliet NI. Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells. Annals of the New York Academy of Sciences 2010;1183:25-37.
111. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008;453:106-9. (Pubitemid 351630329)
112. Kimura A., Naka T., Nohara K., Fujii-Kuriyama Y., Kishimoto T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proceedings of the National Academy of Sciences of the United States of America 2008;105:9721-26. (Pubitemid 352031367)
113. Veldhoen M, Hirota K, Christensen J, O'Garra A, Stockinger B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differen- tiation of Th17 T cells. Journal of Experimental Medicine 2009;206: 43-9.
114. Chakravarthy MV, Lodhi IJ, Yin L, Malapaka RR, Xu HE, Turk J, et al. Identifi-cation of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell 2009;138:476-88.
115. Ema M, Ohe N, Suzuki M, Mimura J, Sogawa K, Ikawa S, et al. Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors. The Journal of Biological Chemistry 1994;269:27337-43. (Pubitemid 24346556)
116. Harper PA, Wong J, Lam MS, Okey AB. Polymorphisms in the human AH receptor. Chemico-Biological Interactions 2002;141:161-87. (Pubitemid 35223210)
117. Clarke L, Zheng-Bradley X, Smith R, Kulesha E, Xiao C, Toneva I, et al. The 1000 Genomes Project: data management and community access. Nature Methods 2012;9:459-62.